The United Kingdom’s drug regulator has found a possible link between the AstraZeneca vaccine and rare blood clotting issues.
The European Medicines Agency has listed blood clotting as a “very rare” side effect of the AstraZeneca jab, but insists the benefits still far outweigh the risks.
A review conducted by the drug regulator found 79 people had suffered blood clots after being administered the shot by the end of March, while 19 had died.
ARTICLE CONTINUES AFTER THIS ADVERTISEMENT
Due to the small risk, the UK is now recommending that healthy people aged between 18-29 be offered alternative jabs.
However, they’re still urging other age groups to continue to receive the AstraZeneca vaccine.
“We will follow today’s updated advice, which should allow people of all ages to continue to have full confidence in vaccines, helping us save lives and cautiously return towards normality,” UK Prime Minister Boris Johnson said.
The Australian Government has now asked the Therapeutic Goods Administration to look into the latest findings from the UK.
Despite the concerns, Queensland Premier Annastacia Palaszczuk has told Sunrise she believes “everyone does have confidence in the vaccine rollout”.